[Surveillance of multi-resistant bacteria in Lorraine: a three-year multicentre incidence study].
OBJECTIVE
Controlling outbreaks of nosocomial infections is a priority for public healthcare in France. This study concerned the incidence of multidrug-resistant bacteria (MDRB) in Lorraine and the impact of the national guidelines for the prevention of MDRB.


METHODS
A multicenter incidence study was conducted for 5 months, in volunteer hospitals. Samples collected for the clinical diagnostic were included. The bacteria studied were: methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella sp., Enterobacter sp., and other Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBL), and vancomycin resistant Enterococci sp.


RESULTS
A total of 30 hospitals were included in the surveillance of MDRB. During the study period (2001-2003), 17874 strains were identified. MRSA reached 29.3% of the 4038 strains of S. aureus, 20.9%, 1.23% and 1.21% of ESBL, respectively, for Enterobacter sp., Klebsiella sp., and other Enterobacteriaceae (for 895, 1061 and 9419 strains). Overall, the incidence of MRSA reached 0.55 per 1000 hospital-days and 0.087 for Enterobacter sp. The incidence increased during the 3 years, from 3.36 to 4.84 per 1000 new patients for MRSA, and from 0.43 to 0.90 for Enterobacter sp.


CONCLUSIONS
Despite guidelines on isolation, MRSA remains poorly controlled and requires more efficient measures. Surveillance of ESBL should be improved.
Ducki
S
S
Service d'hygiène hospitalière, CHRU Nancy, 5, allée du Morvan, 54511 Vandoeuvre-les-Nancy, France. c.s.ducki@libertysurf.fr
Blech
M F
MF
D001419:Bacteria / Q000187:drug effects* / Q000472:pathogenicity; D001424:Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology*; D003428:Cross Infection; D018432:Drug Resistance, Multiple; D005602:France; D006761:Hospitals / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D011159:Population Surveillance